This webinar covered

With recent technological advancements and the discovery of more associations between microbiome in the human body, the spectrum of infectious diseases targeted by microbiome therapies has expanded considerably. In our recent webinar, we explored this evolving landscape as a result of recent FDA approvals, the ongoing focuses on gastrointestinal infections, and other infections, and how this affects the top disease indications at the forefront for microbiome drug developers in the coming years.

Key aspects explored include:

  • A comprehensive overview of the current drug space in targeting infectious diseases
  • Insights into the developers within the infectious diseases space and analysis of the two most active sectors
  • Emerging trends: What the clinically active landscape tells us about how the space will evolve
Hosted by


Webinar Leaders

House Speaker

Ada Lam
Microbiome Lead Research Analyst


Manette Arulanandam
Account Manager

Speak with our team about Beacon Microbiome

What is Beacon Microbiome?


Beacon Microbiome covers all pharmaceutical grade microbiome-based therapeutics across all disease indications. The database includes:

  • Live biotherapeutics
  • Whole ecosystem-derived products
  • Inactivated microbes
  • Bacteriophages
  • Microbiome targeting molecules
  • Microbiome sourced molecules

All nutraceuticals, dietary supplements, medical foods and diagnostics are excluded.

Find out more

How Beacon Microbiome Works

Search the trial and drug landscape by disease, microbial species, and therapy type, alongside other search criteria to instantly extract the data points you need to conduct more complex analyses.

Our unique Milestones filter and visualization highlights past, present, and future drug development milestones including drug and trial readouts, asset history, and regulatory announcements. This enhancement provides an accurate, timely, and exhaustive single-drug timeline allowing you to benchmark progress in the microbiome space.







Contact Us

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more